Found review
Identical low pricing on both molecules plus built-in coaching — the flat-fee simplicity is a real time-saver if you also want a little accountability.
- Semaglutide
- $129/mo
- Pricing
- Flat
- First dose
- About a week
- Coverage
- All 50 states
The Rx-Readiness scorecard
Found scored on our six readiness factors. See the methodology.
What we like
- Low, identical flat pricing on both molecules — switching costs you nothing
- Coaching baked in, useful if you want structure without booking a separate service
- Nationwide, with a mostly async onboarding flow
The caveats
- The coaching-subscription model isn't for everyone
- Compounded only — no brand or oral option
- Support cadence can feel program-driven rather than on-demand
The bottom line
Best for: Parents who want low, identical pricing on either molecule and don't mind a coaching-subscription wrapper around the medication. Identical low pricing on both molecules plus built-in coaching — the flat-fee simplicity is a real time-saver if you also want a little accountability.
Ranked #3 of 7 on our shortlist — see our #1 pick, CoreAge Rx, for comparison.
Compare with the rest of the shortlist
The other 6 providers we've reviewed, in ranking order.
- #1CoreAge Rx— The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.94/100
- #2Eden— A high-disclosure program with clean async onboarding and both molecules nationwide — you pay more, but the price and the process are legible.89/100
- #4Hims & Hers— A polished, app-first mass-market brand with a fast async funnel — dependable and familiar, though tirzepatide pricing isn't consistently posted.87/100
- #5Ro— A heavyweight platform with brand-name access and insurance navigation — powerful if you want FDA-approved product, but the compounded pricing is opaque and can slow a quick decision.86/100
- #6Henry Meds— A flat-fee compounded pioneer — the model is simple and predictable, which is the point, though it now sits at the pricier end with no molecule-switch discount.85/100
- #7Mochi Health— A genuinely support-forward program with a strong care team and fair pricing — but limited state coverage and tiered pricing make it a slower, narrower fit for a quick nationwide decision.82/100
Pricing, states and features reflect Found's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on Found's site. Not medical advice; see our disclosure.